跳至主要内容
临床试验/DRKS00033528
DRKS00033528尚未招募不适用

Clinical Performance Evaluation of Sansure Novel Coronavirus (2019-nCoV) Nucleic Acid Diagnostic Kit (PCR-Fluorescence Probing) - REQA_23005_SNSR

Sansure Biotech Inc.0 个研究点目标入组 600 人开始时间: 2024年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
600

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
7 Years 至 one(—)
性别
All

入选标准

  • 1. Age: = 18: Able to sign the informed consent form (ICF) independently. 2. Age: =7 years and <18 years; Signing the consent form (ICF) by first degree relative upon consent of the minor patient.
  • 3. Participants who agree to the utilization of their samples for processing, storage, analysis, documentation, optional shipment as required by the applied SARS-CoV-2 test and publication of study results in anonymized manner
  • 4. Subject must be presenting with 1 or more of the signs and symptoms of a respiratory infection. Experiencing at least one symptom of COVID-19 for 3 days or fewer from study enrolment (as far as possible).

排除标准

  • 1. Vaccinated against COVID-19 within the last 48 hours
  • 2. Ear, nose and throat (ENT) surgery within the last six months and/or encephalocele
  • 3. Haemophilia and/or using anticoagulant drugs
  • 4. Lack of compliance or other reasons that precludes satisfactory participation in the study as judged by the Investigator
  • 5. Inability to understand the nature of, extent of, and procedures required by the study as judged by the Investigator
  • 6. Participants who are dependent of the sponsor/investigator in any way.

研究者

相似试验